Cargando…

Correction to: LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis

Detalles Bibliográficos
Autores principales:	Wu, Liangcai, Zhu, Lifei, Li, Yanchang, Zheng, Zhixin, Lin, Xi, Yang, Chaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212568/ https://www.ncbi.nlm.nih.gov/pubmed/32425693 http://dx.doi.org/10.1186/s12935-020-01239-2

Ejemplares similares

LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis
por: Wu, Liangcai, et al.
Publicado: (2020)

LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022)

LncRNA POU3F3 promotes melanoma cell proliferation by downregulating lncRNA MEG3
por: Liu, Yingnan, et al.
Publicado: (2021)

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR‐9‐5p/QKI‐5 axis
por: Wu, Meng, et al.
Publicado: (2018)

The lncRNA MEG3 downregulation leads to osteoarthritis progression via miR-16/SMAD7 axis
por: Xu, Jin, et al.
Publicado: (2017)

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis
por: Wang, Pei, et al.
Publicado: (2017)

LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8
por: Jia, Hai-Yan, et al.
Publicado: (2019)

Tumor-Suppressive Function of lncRNA-MEG3 in Glioma Cells by Regulating miR-6088/SMARCB1 Axis
por: Gong, Xin, et al.
Publicado: (2020)

The lncRNA MEG3/miRNA-21/P38MAPK axis inhibits coxsackievirus 3 replication in acute viral myocarditis
por: He, Feng, et al.
Publicado: (2023)

Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
por: Ye, Weiping, et al.
Publicado: (2019)

lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p
por: Long, Jianwen, et al.
Publicado: (2018)

HNRNPA2B1-mediated m(6)A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
por: Li, Ke, et al.
Publicado: (2023)

lncRNA MEG3 Suppresses the Progression of Ankylosis Spondylitis by Regulating the Let-7i/SOST Axis
por: Ma, Junjie, et al.
Publicado: (2020)

LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis
por: Liu, Ping, et al.
Publicado: (2019)

LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR‐23a/APAF‐1 axis
por: Zhang, Xiaowen, et al.
Publicado: (2019)

The Association of MEG3 lncRNA with Nuclear Speckles in Living Cells
por: Hasenson, Sarah E., et al.
Publicado: (2022)

A review on the role of MEG8 lncRNA in human disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
por: Zhou, Xiangyu, et al.
Publicado: (2017)

LncRNA GAS5 Suppresses Colorectal Cancer Progress by Target miR-21/LIFR Axis
por: Xie, Juan, et al.
Publicado: (2022)

LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy
por: Huang, Xin, et al.
Publicado: (2021)

Novel lncRNA SNHG16 Promotes the Growth and Metastasis of Malignant Melanoma by Regulating miR-205-5p/PAK2 Axis
por: Xia, Yun, et al.
Publicado: (2022)

lncRNA MEG3 Promotes PDK4/GSK-3β/β-Catenin Axis in MEFs by Targeting miR-532-5p
por: Yang, Yuan-Yuan, et al.
Publicado: (2023)

Depletion of lncRNA MEG3 Ameliorates Imatinib-Induced Injury of Cardiomyocytes via Regulating miR-129-5p/HMGB1 Axis
por: Tang, Peng, et al.
Publicado: (2023)

LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis
por: Guo, Kai, et al.
Publicado: (2021)

LncRNA HLA-F-AS1 Enhances the Migration, Invasion and Apoptosis of Glioblastoma Cells by Targeting lncRNA MEG3
por: Wang, Yanhua, et al.
Publicado: (2021)

A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma
por: Mo, Xiaocong, et al.
Publicado: (2022)

The lncRNA MEG3 promotes trophoblastic cell growth and invasiveness in preeclampsia by acting as a sponge for miR-21, which regulates BMPR2 levels
por: Liu, Huyi, et al.
Publicado: (2021)

Methylene blue relieves the development of osteoarthritis by upregulating lncRNA MEG3
por: Li, Xinyi, et al.
Publicado: (2018)

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
por: Yu, Fujun, et al.
Publicado: (2018)

LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4
por: Ning, Jiayu, et al.
Publicado: (2020)

STAT3-induced upregulation of lncRNA MEG3 regulates the growth of cardiac hypertrophy through miR-361-5p/HDAC9 axis
por: Zhang, Jingchang, et al.
Publicado: (2019)

LncRNA MEG3 Protects Chondrocytes From IL-1β-Induced Inflammation via Regulating miR-9-5p/KLF4 Axis
por: Huang, Yijiang, et al.
Publicado: (2021)

lncRNA MEG3 aggravated neuropathic pain and astrocyte overaction through mediating miR-130a-5p/CXCL12/CXCR4 axis
por: Dong, Jiacai, et al.
Publicado: (2021)

LncRNA Meg3 promotes oxygen and glucose deprivation injury by decreasing angiogenesis in hBMECs by targeting the miR‑122‑5p/NDRG3 axis
por: Luo, Zhaoliang, et al.
Publicado: (2022)

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
por: Wei, Qing, et al.
Publicado: (2023)

LncRNA DANCR regulates lymphatic metastasis of bladder cancer via the miR-335/VEGF-C axis
por: Ping, Qinrong, et al.
Publicado: (2021)

Downregulation of lncRNA MEG3 and miR-770-5p inhibit cell migration and proliferation in Hirschsprung’s disease
por: Li, Hongxing, et al.
Publicado: (2017)

Correction: LncRNA-MEG3 inhibits activation of hepatic stellate cells through SMO protein and miR-212
por: Yu, Fujun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vf91qsm1liu8uuf7lfsm1huo02